If you look at the more recent announcements, there are 4 words that made the whole world of difference in today's announcement:
11 October 2019 OncoSil provides positive regulatory updates for OncoSil™ device forboth EU and the USA
We look forward to updating the market on the progress of our CEMark application.
28 October 2019 OncoSil submits updated Clinical Evaluation Report to BSI
BSI is expected to review the CER to inform a final determination on OncoSil device’s CE Mark approval.
31 October 2019 Quarterly Activities & Cash Flow ReportQuarter ended 30 September 2019
The Company will keep the market informed of developments with respect to progress on the final CEMarking determination.
1 November 2019 "Positive CE Mark Status Report received from Notified Body BSI"
The Company will continue to keep the market informed of developments during the final phase of thereview.
30 January 2020 Quarterly Activities & Cash Flow ReportQuarter ended 31 December 2019
The Company would expect the final determination in the coming weeks.
- Forums
- ASX - By Stock
- Ann: Appendix 4C - quarterly
If you look at the more recent announcements, there are 4 words...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add OSL (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.7¢ |
Change
-0.001(12.5%) |
Mkt cap ! $31.31M |
Open | High | Low | Value | Volume |
0.8¢ | 0.8¢ | 0.7¢ | $19.71K | 2.475M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
59 | 25681033 | 0.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.8¢ | 5068750 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
57 | 25081033 | 0.007 |
24 | 9065065 | 0.006 |
14 | 14110000 | 0.005 |
8 | 8512824 | 0.004 |
2 | 2839966 | 0.003 |
Price($) | Vol. | No. |
---|---|---|
0.008 | 5000000 | 1 |
0.009 | 11069552 | 12 |
0.010 | 18360330 | 17 |
0.011 | 9257225 | 18 |
0.012 | 7560752 | 5 |
Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
Featured News
OSL (ASX) Chart |
The Watchlist
EQN
EQUINOX RESOURCES LIMITED.
Zac Komur, MD & CEO
Zac Komur
MD & CEO
SPONSORED BY The Market Online